De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy

Transplantation

Volumn 94, Issue 2, 2012, Pages 172-177

  Willicombe, Michelle ^a   Brookes, Paul ^b   Sergeant, Ruhena ^b   Santos Nunez, Eva ^b   Steggar, Corinna ^b   Galliford, Jack ^a   McLean, Adam ^a   Cook, Terence H ^b   Cairns, Tom ^a   Roufosse, Candice ^b   Taube, David ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Antibody mediated rejection; Donor specific antibodies; HLA DQ antigens; HLA matching; Renal transplantation

Indexed keywords

ALEMTUZUMAB; CORTICOSTEROID; ECULIZUMAB; HLA A ANTIGEN; HLA ANTIBODY; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN; HLA CW ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; HUMAN IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ANTIBODY MEDIATED REJECTION; ARTICLE; BLOOD GROUP TYPING; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; FEMALE; GLOMERULOPATHY; GRAFT SURVIVAL; HUMAN; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PLASMAPHERESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; LINKAGE DISEQUILIBRIUM; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84864283447     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182543950     Document Type: Article

References (26)

1. Ting A, Morris PJ. Powerful effect of HL-DR matching on survival of cadaveric renal allografts. Lancet 1980; 2(8189): 282.
2. Gilks WR, Bradley BA, Gore SM, et al. Substantial benefits of tissue matching in renal transplantation. Transplantation 1987; 43(5): 669.
3. Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007; 7(2): 408.
4. Willicombe M, Roufosse C, Brookes P, et al. Antibody-mediated rejection after alemtuzumab induction: incidence risk factors and predictors of poor outcome. Transplantation 2011; 92: 176.
5. Worthington JE, Martin S, Al-Husseini DM, et al. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 2003; 75(7): 1034.
6. Issa N, Cosio FG, Gloor JM, et al. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation 2008; 86(5): 681.
7. Musat AI, Agni RM, Wai PY, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant 2011; 11(3): 500.
8. Smith JD, Banner NR, Hamour IM, et al. De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival. Am J Transplant 2011; 11(2): 312.
9. Palmer SM, Davis RD, Hadjiliadis D, et al. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Transplantation 2002; 74(6): 799.
10. Freedman BI, Thacker LR, Heise ER, et al. HLA-DQ matching in cadaveric renal transplantation. Clin Transplant 1997; 11: 480.
11. Hsia S, Tong JY, Parris GL, et al. Molecular compatibility and renal graft survivalVthe HLA DRB1 genotyping. Transplantation 1993; 55(2): 395.
12. Bushell A, Higgins RM, Wood KJ, et al. HLA-DQ mismatches between donor and recipient in the presence of HLA-DR compatibility do not influence the function or outcome of renal transplants. Hum Immunol 1989; 26(3): 179.
13. Navarrete C, Jaraquemada D, Fainboim L, et al. Genetic and functional relationship of the HLA-DR and HLA-DQ antigens. Immunogenetics 1985; 21(1): 97.
14. Gibbs VC, Wood DM, Garovoy MR. The response of cultured human kidney capillary endothelium to immunologic stimuli. Hum Immunol 1985; 14(3): 259.
15. El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney loss. Am J Transplant 2009; 9(3): 527.
16. Albert ED, Baur MP, Mayr WR, eds. Histocompatibility Testing 1984. Heidelberg, Germany: Springer-Verlag; 1984.
17. Available at: http://www.ihwg.org/about/history.html. Accessed April 15, 2011.
18. Cooper JE, Gralla J, Cagle L, et al. Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes. Transplantation 2011; 91(10): 1103.
19. Gloor JM, Sethi S, Stegall MD, et al. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007; 7(9): 2124.
20. Campos EF, Tedesco-Silva H, Machado PG, et al. Post-transplant anti- HLA class II antibodies as risk factor for late kidney allograft failure. Am J Transplant 2006; 6(10): 2316.
21. Kobayashi T, Maruya E, Niwa M, et al. Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation. Hum Immunol 2011; 72(1): 11.
22. Iniotaki-Theodoraki AG, Boletis JN, Trigas GCh, et al. Humoral immune reactivity against human leukocyte antigen (HLA)-DQ graft molecules in the early posttransplantation period. Transplantation 2003; 75(9): 1601.
23. Zhu L, Lee PC, Everly MJ, et al. Detailed examination of HLA antibody development on renal allograft failure and function. Clin Transpl 2008: 171.
24. Chan K, Taube D, Roufosse C, et al. Kidney transplantation with minimized maintenance: alemtuzumab induction with tacrolimus monotherapyVan open label, randomized trial. Transplantation 2011; 92(7): 774.
25. Levine DJ, Coalson J, Pollack M, et al. Detection of HLA-II-DQ Donor specific antibody in lung transplant recipients is associated with severe histopathological changes and impaired graft survival even in the absence of other DSAs and positive C4d immunostaining. Chest 2009; 136: 17S.
26. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8(4): 753.